Literature DB >> 6282959

Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.

L A Ashworth, R B Fitzgeorge, L I Irons, C P Morgan, A Robinson.   

Abstract

Two Bordetella pertussis antigen preparations, outer membrane protein (OMP) and filamentous haemagglutinin (FHA), and a standard vaccine were used to immunize rabbits, and the effects on nasopharyngeal colonization by the organism were determined. Antibodies were measured in serum and in nasal washes by ELISA before and after challenge of the rabbits with 10(6) bacteria of strain M2. Recoveries of B. pertussis in nasal washes were used to assess colonization, which in controls persisted for at least 65 days. Some rabbits of all the immunized groups showed enhanced clearance, but there was no correlation between the elimination of B. pertussis and serum antibodies to OMP, FHA, lipopolysaccharide, lymphocytosis-promoting factor or agglutinogen 3. In contrast, nasal IgA antibody to FHA showed significant inverse correlation with bacterial persistence. Such antibody was induced by the OMP preparation as well as by FHA, but to different extents depending on the immunization schedule and adjuvant used.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282959      PMCID: PMC2134090          DOI: 10.1017/s0022172400070339

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  23 in total

1.  The stability of the serotypes of Bordetella pertussis with particular reference to serotype 1,2,3,4.

Authors:  C J Bronne-Shanbury; J M Dolby
Journal:  J Hyg (Lond)       Date:  1976-04

2.  Scanning electron microscopic study of hamster tracheal organ cultures infected with Bordetella pertussis.

Authors:  K E Muse; A M Collier; J B Baseman
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Effectiveness of orally administered Bordetella pertussis vaccine in mice.

Authors:  H Hof; H Finger; L Körner; L Milcke
Journal:  Dev Biol Stand       Date:  1976

4.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

5.  Experimental pertussis infection in the rabbit: similarities with infection in primates.

Authors:  N W Preston; R M Timewell; E J Carter
Journal:  J Infect       Date:  1980-09       Impact factor: 6.072

Review 6.  Mucosal immunology.

Authors:  J Bienenstock; A D Befus
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

7.  Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses.

Authors:  M Pittman; B L Furman; A C Wardlaw
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

8.  Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.

Authors:  Y Sato; H Arai; K Suzuki
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

9.  Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R L Cole
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  [Preliminary findings with oral whooping cough vaccination in young infants (author's transl)].

Authors:  H Maurer; K H Höfler; W Hilbe; E G Huber
Journal:  Wien Klin Wochenschr       Date:  1979-11-09       Impact factor: 1.704

View more
  13 in total

1.  Progress towards a new pertussis vaccine.

Authors:  E Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

2.  Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.

Authors:  L A Ashworth; L I Irons; A B Dowsett
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.

Authors:  A C Blaskett; J C Cox
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

4.  Purification and characterization of fimbriae isolated from Bordetella pertussis.

Authors:  J M Zhang; J L Cowell; A C Steven; P H Carter; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

Review 5.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.

Authors:  A Robinson; D C Hawkins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.

Authors:  A Robinson; L I Irons
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms.

Authors:  Victoria J Chalker; Crista Toomey; Shaun Opperman; Harriet W Brooks; Michael A Ibuoye; Joe Brownlie; Andrew N Rycroft
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

9.  Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  F Fish; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.